Morning Report: 10/9/2012

MR is back from a small hiatus (vacation!). Here’s Dr. McMillan with today’s edition:

 

Here’s the case:

You have a 47 year-old male who presents with shortness of breath and leg weakness…

 

Myasthenia Gravis and Myasthenic Crisis

Myasthenia gravis (Gr mya- muscle; asthenia- paralysis; gravis- grave or serious): A disorder of the neuromuscular junction wherein the body produces antibodies against the motor-endplate acetylcholine receptor (AChR) that results in a “characteristic and striking fluctuating weakness and fatigability of muscle.”

 

Epidemiology and Pathophysiology

Females affected most from second to third decade, and around 70. Males from fifth to eighth decades. Anti-AChR antibodies cause a reduction in the number and function of AChR at the motor endplate. This in turn results in muscle weakness. Correlation between blood levels of anti-AChR antibodies and severity of disease.

 

Clinical features

  • Generalized muscle weakness
  • Proximal muscle groups
  • Neck, bulbar and facial muscle weakness
  • Ptosis and diplopia most common
  • Can present with dyspnea

 

MG patients on therapy can present with myasthenic crisis — inadequate ACh present in the neuromuscular junction, OR in cholinergic crisis, where there is too much ACh in the junction. Diagnosis includes use of assays for anti-AChR antibody level, electromyographic studies, and the edrophonium test. Edrophonium a diagnostic option, but comes with significant risks and not frequently implemented in ER setting.

 

The most critical complication is respiratory failure. Status best measured with pulmonary function tests:

 

Table: Pulmonary Function Tests in Patients with Myasthenic Crisis

    Normal Criteria for Intubation

Vital capacity

  > 60 mL/kg  15 mL/kg

Negative inspiratory force

  > 70 cm H2O < 20 cm H2O

Positive expiratory force

  > 100 cm H2O < 40 cm H2O

Adapted from: Mayer SA. Intensive care of the myasthenic patient. NEUROLOGY 1997;48 (Suppl 5): S70-S75.

 

Acute management

  • Supportive: Manage respiratory failure and poor tolerance of oral secretions
  • Medical: Cover for any concomitant infection and treat fever, IVIG vs plasmapheresis

 

Pitfalls

  • Not recognizing or addressing threat of impending respiratory failure
  • Not recognizing/treating concomitant infection

 

References:

Mayer SA. Intensive care of the myasthenic patient. NEUROLOGY 1997;48 (Suppl 5): S70-S75.

 

Ropper AH, Samuels MA. Chapter 53. Myasthenia Gravis and Related Disorders of the Neuromuscular Junction. In: Ropper AH, Samuels MA, eds. Adams and Victor’s Principles of Neurology. 9th ed. New York: McGraw-Hill; 2009. http://www.accessmedicine.com/content.aspx?aID=3642849. Accessed September 16, 2012.

 

Sloan EP, Handel DA, Gaines SA. Chapter 167. Chronic Neurologic Disorders. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York: McGraw-Hill; 2011. http://www.accessemergencymedicine.com/content.aspx?aID=6366264. Accessed September 16, 2012.

 

Yavagal DR and Mayer SA. Respiratory Complications of Rapidly Progressive Neuromuscular Syndromes: Guillain-Barré Syndrome and Myasthenia Gravis. Seminars in Respiratory and Critical Care Medicine. Vol 23 (3) 2002, p221-229.

 

Thanks Dr. McMillan! Leave any comments below.

The views expressed on this blog are the author's own and do not reflect the views of their employer. Please read our full disclaimer here. Any references to clinical cases refer to patients treated at a virtual hospital, Janus General Hospital.
The following two tabs change content below.

Jay Khadpe MD

Editor in Chief of "The Original Kings of County" Assistant Professor of Emergency Medicine Assistant Residency Director SUNY Downstate / Kings County Hospital

Latest posts by Jay Khadpe MD (see all)